Fernando Bordet Villa, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 41a Calle Orquidea, Canovanas, PR 00729 Phone: 787-256-5659 |
Dr. Joaquin R. Mendez Sr., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Carr.185 Km5.5 ,bo. Campo Rico, Canovanas, PR 00729 Phone: 787-615-9292 Fax: 787-886-6847 |
Antulio Casiano Sosa, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Carr 185 Km 15.5, Bo. Cedros, Canovanas, PR 00729 Phone: 787-750-1250 Fax: 787-750-1250 |
Mrs. Yngrid B Lithgow Ramirez, MD Family Medicine Medicare: Medicare Enrolled Practice Location: Urb Loiza Valley, Mm Medical, Canovanas, PR 00738 Phone: 787-273-1227 |
Lizzette Montalvo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 335 Calle Flor De Nono, Canovanas, PR 00729 Phone: 787-596-3390 Fax: 787-998-0735 |
Mrs. Katia Larisa Mercado, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Hc 1 Box 5123, Canovanas, PR 00729 Phone: 787-256-7843 Fax: 787-876-7416 |
News Archive
CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the third quarter ended September 30, 2011.
Stem cell technology has long offered the hope of regenerating tissue to repair broken or damaged neural tissue. Findings from a team of UC Davis investigators have brought this dream a step closer by developing a method to generate functioning brain cells that produce myelin - a fatty, insulating sheath essential to normal neural conduction.
A UK study supports a role for interhemispheric disconnectivity in bipolar disorder, showing reduced corpus callosum area and thickness in patients with the condition.
The Department of Justice takes the position that the Florida judge's ruling in which he threw out the health law is "indefensible."
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
› Verified 8 days ago